International Journal of Advanced Biomedicine
Journal license

Journal

International Journal of Advanced Biomedicine


Volume
& Issue

Volume 1, Issue 1


Published
on

May 1, 2016


Pages

21-27


DOI

Article

Personalised Cancers Treatment for Children, Teenagers, and Young Adults (CTYA)

Check for updates


Authors

Hisham Morsi* Affiliation:
Faculty of Health and Social Care Sciences, Kingston University and St George's University of London, UK; Medical Research Centre, HMC, Doha, Qatar


Abstract

Cancer treatment has gone through several decades of treatment strategies of phase I, phase II and randomized controlled trials until reaching the current phase of successful treatment that approaches >95% cure rates in some paediatric based chemotherapy protocols. However some diseased are still not curable despite the use of combinations of surgery, chemotherapy, radiotherapy, immunotherapy, hormonal treatments, biological modifiers, novel agents and stem cell transplants (autologous and allogeneic). Such diseases are demanding alternative approaches and hence the oncology community is heading towards personalised management approaches. Here we present an overview of the precise medications approaches that have been tried by different teams. The near future would include a combinations of these approaches to gain better understanding of the disease and achieve better outcomes.


Keywords

Personalised medicine, Genomic profiling, Live kinetic cytotoxicity assay, Xenografts


Citation

Morsi, H. (2016). Personalised cancers treatment for children, teenagers, and young adults (CTYA). International Journal of Advanced Biomedicine, 1(1), 21–27. https://doi.org/10.18576/ab/010105

Published by: Engineering Journals

Engineering Journals Logo